Eight years after Fiji's 2008 and 2009 HPV vaccination campaign, a single dose of the quadrivalent vaccine was 81% effective against HPV 16 and 18 in 822 young pregnant women.
In 2008 and 2009 Fiji vaccinated more than 30,000 girls aged 9 to 12 with the quadrivalent HPV vaccine; coverage for at least one dose was over 60%, with 14% receiving one dose only, 13% two and 35% three. This retrospective cohort study, run from 2015 to 2019, enrolled pregnant women aged 23 or under who had been eligible for the vaccine and whose vaccination status was confirmed, a median of eight years after vaccination. It was funded by the Bill and Melinda Gates Foundation and the Australian Government.
One dose of HPV vaccine gave lasting protection against the two types that cause most cervical cancers, in a Pacific island setting.
Shares Ministry of Health and Medical Services, Fiji, Cervical cancer.
Shares Ministry of Health and Medical Services, Fiji, Cervical cancer.
Shares Ministry of Health and Medical Services, Fiji, Cervical cancer.
Shares Ministry of Health and Medical Services, Fiji, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/